| Winkelmann Sons Drug Co | |
| 3300 Meramec Street, St Louis, Missouri 63118 | |
| (314) 353-3300 |
| Name | Winkelmann Sons Drug Co |
|---|---|
| Organization Name | Winkelmann Sons Drug Co |
| Location | 3300 Meramec Street, St Louis, Missouri 63118 |
| Type | Community/Retail Pharmacy |
| Phone | (314) 353-3300 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Financed as a European Union Twinning project, Johannes Gutenberg University Mainz and Masaryk University, the second-largest university in the Czech Republic, have announced plans for close cooperation with regard to research into ribonucleic acids.
Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the rapidly emerging field of cancer metabolism, today announced the publication of a paper in Cancer Cell that illuminates the mechanism by which 2-hydroxyglutarate (2HG), and the mutations in the metabolic genes IDH1 and IDH2 that produce it, may be driving the growth of tumors in patients with acute myeloid leukemia (AML).
New research published in this month's Rheumatology journal has found that having gout doubles the risk of heart attack and stroke. The research tracked the health of more than 205,000 gout patients using data spanning five decades to determine links between gout and heart attack and stroke.
Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.
› Verified 1 days ago
| NPI Number | 1407862881 |
| Organization Name | WINKELMANN SONS DRUG CO |
| Type | Community/Retail Pharmacy |
| Address | 3300 Meramec St, Saint Louis, MO 63118 |
| Phone Number | 314-353-3300 |
News Archive
Financed as a European Union Twinning project, Johannes Gutenberg University Mainz and Masaryk University, the second-largest university in the Czech Republic, have announced plans for close cooperation with regard to research into ribonucleic acids.
Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the rapidly emerging field of cancer metabolism, today announced the publication of a paper in Cancer Cell that illuminates the mechanism by which 2-hydroxyglutarate (2HG), and the mutations in the metabolic genes IDH1 and IDH2 that produce it, may be driving the growth of tumors in patients with acute myeloid leukemia (AML).
New research published in this month's Rheumatology journal has found that having gout doubles the risk of heart attack and stroke. The research tracked the health of more than 205,000 gout patients using data spanning five decades to determine links between gout and heart attack and stroke.
Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.
› Verified 1 days ago
| NPI Number | 1528556479 |
| Organization Name | WINKELMANN SONS DRUG CO |
| Doing Business As | WINKELMANN SONS DRUG CO |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 3300 Meramec St, Saint Louis, MO 63118 |
| Phone Number | 314-353-3300 |
News Archive
Financed as a European Union Twinning project, Johannes Gutenberg University Mainz and Masaryk University, the second-largest university in the Czech Republic, have announced plans for close cooperation with regard to research into ribonucleic acids.
Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the rapidly emerging field of cancer metabolism, today announced the publication of a paper in Cancer Cell that illuminates the mechanism by which 2-hydroxyglutarate (2HG), and the mutations in the metabolic genes IDH1 and IDH2 that produce it, may be driving the growth of tumors in patients with acute myeloid leukemia (AML).
New research published in this month's Rheumatology journal has found that having gout doubles the risk of heart attack and stroke. The research tracked the health of more than 205,000 gout patients using data spanning five decades to determine links between gout and heart attack and stroke.
Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.
› Verified 1 days ago
| NPI Number | 1710991161 |
| Organization Name | WINKELMANN SONS DRUG CO |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 3300 Meramec St, Saint Louis, MO 63118 |
| Phone Number | 314-353-3300 |
News Archive
Financed as a European Union Twinning project, Johannes Gutenberg University Mainz and Masaryk University, the second-largest university in the Czech Republic, have announced plans for close cooperation with regard to research into ribonucleic acids.
Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the rapidly emerging field of cancer metabolism, today announced the publication of a paper in Cancer Cell that illuminates the mechanism by which 2-hydroxyglutarate (2HG), and the mutations in the metabolic genes IDH1 and IDH2 that produce it, may be driving the growth of tumors in patients with acute myeloid leukemia (AML).
New research published in this month's Rheumatology journal has found that having gout doubles the risk of heart attack and stroke. The research tracked the health of more than 205,000 gout patients using data spanning five decades to determine links between gout and heart attack and stroke.
Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.
› Verified 1 days ago
| NPI Number | 1750324018 |
| Organization Name | WINKELMANN SONS DRUG CO |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 3300 Meramec St, Saint Louis, MO 63118 |
| Phone Number | 314-353-3300 |
News Archive
Financed as a European Union Twinning project, Johannes Gutenberg University Mainz and Masaryk University, the second-largest university in the Czech Republic, have announced plans for close cooperation with regard to research into ribonucleic acids.
Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the rapidly emerging field of cancer metabolism, today announced the publication of a paper in Cancer Cell that illuminates the mechanism by which 2-hydroxyglutarate (2HG), and the mutations in the metabolic genes IDH1 and IDH2 that produce it, may be driving the growth of tumors in patients with acute myeloid leukemia (AML).
New research published in this month's Rheumatology journal has found that having gout doubles the risk of heart attack and stroke. The research tracked the health of more than 205,000 gout patients using data spanning five decades to determine links between gout and heart attack and stroke.
Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.
› Verified 1 days ago
News Archive
Financed as a European Union Twinning project, Johannes Gutenberg University Mainz and Masaryk University, the second-largest university in the Czech Republic, have announced plans for close cooperation with regard to research into ribonucleic acids.
Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the rapidly emerging field of cancer metabolism, today announced the publication of a paper in Cancer Cell that illuminates the mechanism by which 2-hydroxyglutarate (2HG), and the mutations in the metabolic genes IDH1 and IDH2 that produce it, may be driving the growth of tumors in patients with acute myeloid leukemia (AML).
New research published in this month's Rheumatology journal has found that having gout doubles the risk of heart attack and stroke. The research tracked the health of more than 205,000 gout patients using data spanning five decades to determine links between gout and heart attack and stroke.
Northwest Biotherapeutics announced today that the Company is resuming enrollment of additional new patients into its ongoing 240-patient, double blind, randomized, placebo controlled Phase II clinical trial of DCVax for Glioblastoma multiforme brain cancer.
› Verified 1 days ago
Amann's Orthopedics Inc Type: DME Supplier - Customized Equipment Location: 2821 N Ballas Rd, St Louis, Missouri 63131 Phone: (314) 567-6649 | |
Dierberg Heritage Place Pharmacy Type: Pharmacy Location: 12595 Olive Street Rd, St Louis, Missouri 63141 Phone: (314) 542-2194 | |
Dierbergs West Oak Pharmacy Type: Pharmacy Location: 11481 Olive Street Road, St Louis, Missouri 63141 Phone: (314) 432-5708 | |
Kci Usa Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2338 Weldon Pkwy, St Louis, Missouri 63146 Phone: (314) 997-9102 | |
Medcuro O & P Type: Durable Medical Equipment & Medical Supplies Supplier Location: 11605 Studt Ave, St Louis, Missouri 63141 Phone: (314) 567-8595 |